PHATHOM PHARMACEUTICALS INC's ticker is PHAT and the CUSIP is 71722W107. A total of 95 filers reported holding PHATHOM PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,501,119 | -21.8% | 144,756 | +8.0% | 0.00% | – |
| Q2 2023 | $1,918,823 | +101.1% | 133,996 | +0.3% | 0.00% | – |
| Q1 2023 | $954,000 | +65738.5% | 133,587 | +3.4% | 0.00% | – |
| Q4 2022 | $1,449 | -99.9% | 129,149 | -24.6% | 0.00% | – |
| Q3 2022 | $1,899,000 | +31.8% | 171,370 | +0.3% | 0.00% | – |
| Q2 2022 | $1,441,000 | -39.7% | 170,787 | -2.7% | 0.00% | – |
| Q1 2022 | $2,389,000 | -29.6% | 175,562 | +1.7% | 0.00% | – |
| Q4 2021 | $3,394,000 | -37.4% | 172,561 | +2.1% | 0.00% | -100.0% |
| Q3 2021 | $5,425,000 | +1197.8% | 168,988 | +1268.9% | 0.00% | – |
| Q2 2021 | $418,000 | -94.3% | 12,345 | -93.6% | 0.00% | -100.0% |
| Q1 2021 | $7,300,000 | +17.5% | 194,374 | +3.9% | 0.00% | 0.0% |
| Q4 2020 | $6,212,000 | +6.8% | 187,006 | +15.0% | 0.00% | 0.0% |
| Q3 2020 | $5,819,000 | +10.4% | 162,595 | +1.5% | 0.00% | 0.0% |
| Q2 2020 | $5,269,000 | +5690.1% | 160,119 | +4418.0% | 0.00% | – |
| Q1 2020 | $91,000 | -16.5% | 3,544 | +1.0% | 0.00% | – |
| Q4 2019 | $109,000 | – | 3,509 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Medicxi Ventures Management (Jersey) Ltd | 2,067,861 | $77,669,000 | 45.24% |
| FRAZIER MANAGEMENT LLC | 5,827,415 | $218,878,000 | 17.56% |
| Abingworth LLP | 1,203,135 | $45,057,000 | 15.56% |
| Greenspring Associates, LLC | 360,939 | $13,557,000 | 10.78% |
| Penn Mutual Asset Management, LLC | 86,940 | $3,265,000 | 3.69% |
| RA Capital Management | 3,115,008 | $117,000,000 | 1.76% |
| Rhenman & Partners Asset Management AB | 175,000 | $6,573,000 | 0.46% |
| Summit Rock Advisors, LP | 34,100 | $1,281,000 | 0.44% |
| Eventide Asset Management | 600,000 | $22,536,000 | 0.33% |
| Parkman Healthcare Partners LLC | 30,207 | $1,135,000 | 0.26% |